1. Home
  2. AADX vs PGEN Comparison

AADX vs PGEN Comparison

Compare AADX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Aerospace & Defense Inc. Common Stock

AADX

Applied Aerospace & Defense Inc. Common Stock

HOLD

Current Price

$9.90

Market Cap

3.3B

Sector

Industrials

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AADX
PGEN
Founded
1900
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
AADX
PGEN
Price
$9.90
$6.39
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
★ $22.88
$13.65
AVG Volume (30 Days)
1.9M
★ 4.6M
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.03
Revenue
N/A
★ $230,981,000.00
Revenue This Year
$36.93
$2,365.68
Revenue Next Year
$15.57
$85.75
P/E Ratio
★ N/A
$220.17
Revenue Growth
N/A
N/A
52 Week Low
$10.31
$3.04
52 Week High
$24.24
$8.98

Technical Indicators

Market Signals
Indicator
AADX
PGEN
Relative Strength Index (RSI) 33.00 36.29
Support Level N/A $6.08
Resistance Level $13.03 $7.44
Average True Range (ATR) 0.75 0.44
MACD 0.01 -0.17
Stochastic Oscillator 6.98 2.37

Price Performance

Historical Comparison
AADX
PGEN

About AADX Applied Aerospace & Defense Inc. Common Stock

Applied Aerospace & Defense Inc specializes in providing engineering and vertically integrated manufacturing solutions for space and defense technology companies. The company builds complex hardware for extreme operating environments, combining deep material science and IP-enabled process expertise with the ability to enable rapid prototyping, enhance new product development, and responsively scale production. The majority of the company's revenue is derived from the sales of Defense Aviation and Airborne Systems, followed by Space and Launch Systems, C5ISR and Precision Strike Systems.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: